Perwyn acquires European Sperm Bank from Axcel

Charles Wheeldon
June 14, 2022
Annemette Arndal-Lauritzen, European Sperm Bank
Annemette Arndal-Lauritzen

London-based private equity investor Perwyn is acquiring European Sperm Bank (ESB) from Danish private equity investment company Axcel in a transaction which is expected to close in the third quarter this year.

Headquartered in Copenhagen, ESB is a provider of donor sperm and related fertility services and has helped thousands of women in more than 90 conceive. Founded in 2004, ESB has built an extensive and diverse donor bank.

Perwyn stated it will invest to expand ESB’s donor bank further, increase its geographic coverage and range of fertility services, as well as extending its quality, compliance and technology.

Martin le Huray, partner at Perwyn said: “We are excited to partner with the ESB team and to support them in their mission to help women and couples across the world make their dream of a family come true. Already one of the largest donor banks in the world, we will be investing to support an exciting range of growth opportunities, including expanding ESB’s bank, its geographic reach and its broader range of fertility services, whilst further enhancing its leading reputation for quality and customer service.”

Annemette Arndal-Lauritzen, chief executive of ESB, added: “We are grateful to Axcel for all its support in the last three years, successfully transforming ESB into a true market leader with an agile organisation and attractive customer offering, including long-term support of families and donor children. We are excited to be joining forces with Perwyn, with their experience of supporting exceptional companies achieve ambitious goals on a global scale, and to working with the Perwyn team to fulfil ESB’s great potential.” 

Andrew Wynn, managing partner of Perwyn, commented: “We are delighted to have the opportunity to invest alongside management into ESB and look forward to supporting the company with the next phase of its expansion plans. This investment is perfectly aligned with Perwyn’s strategy focused on high-growth, mid-market buyouts in the UK and Europe, with the healthcare space being one of our four core sector verticals. We are confident that our entrepreneurial and growth-oriented investment team, backed up by a substantial permanent capital base, will enable Perwyn to act as a highly engaged and supportive partner for growth to ESB in the years ahead.”

Perwyn was advised by Lincoln International, Beyond Advisers, L.E.K. Consulting, Deloitte, Bech-Bruun, Eversheds, Tatsu Partners and Lockton.

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login